ID

23139

Beschreibung

Responsible Party: Teva Pharma GmbH ClinicalTrials.gov Identifier: NCT02384577 History of Changes Other Study ID Numbers: BFS-AS-40074 DRKS00006542 ( Registry Identifier: German Clinical Trials Register ) Study First Received: March 4, 2015 Last Updated: November 3, 2016 Study to Evaluate Satisfaction and Usability of DuoResp® SPIROMAX® in Asthma and COPD Treatment ODM derived from: https://clinicaltrials.gov/ct2/show/NCT02384577

Link

https://clinicaltrials.gov/ct2/show/NCT02384577

Stichworte

Versionen (1)
  1. 25.06.17 25.06.17 -
Hochgeladen am

25. Juni 2017

DOI

Für eine Beantragung loggen Sie sich ein.

Lizenz

Creative Commons BY 4.0
Modell Kommentare :

Hier können Sie das Modell kommentieren. Über die Sprechblasen an den Itemgruppen und Items können Sie diese spezifisch kommentieren.

Zurück zu Modell Kommentaren
Itemgroup Kommentare für :

Item Kommentare für :

Um Formulare herunterzuladen müssen Sie angemeldet sein. Bitte loggen Sie sich ein oder registrieren Sie sich kostenlos.

Eligibility Asthma and COPD Treatment DRKS00006542 NCT02384577 DRKS00006542

Englisch

Eligibility Asthma and COPD Treatment NCT02384577 DRKS00006542

1 Formulare  
Inclusion Criteria
Beschreibung

Inclusion Criteria

Alias
UMLS CUI-1
C1512693
Ages Eligible for Study: 18 Years and older (Adult, Senior)
Beschreibung

Age

Datentyp

boolean

Alias
UMLS CUI [1]
C0001779
Male and female adult patients with clinical diagnosis of bronchial asthma or chronic obstructive pulmonary disease
Beschreibung

Asthma or COPD

Datentyp

boolean

Alias
UMLS CUI [1]
C0004096
UMLS CUI [2]
C0024117
Patients on regular medication with inhaled corticosteroids and long-acting beta-2-agonists in fixed-dose combination
Beschreibung

Inhaled corticosteroids and long-acting beta-2-agonists

Datentyp

boolean

Alias
UMLS CUI [1]
C2065041
UMLS CUI [2,1]
C0001644
UMLS CUI [2,2]
C0205166
Patients who recently changed medication to DuoResp® Spiromax or are about to do so
Beschreibung

Change of medication

Datentyp

boolean

Alias
UMLS CUI [1]
C0580105
Capacitated person with present declaration of consent
Beschreibung

Informed Consent

Datentyp

boolean

Alias
UMLS CUI [1]
C0021430
Exclusion Criteria
Beschreibung

Exclusion Criteria

Alias
UMLS CUI-1
C0680251
Diseases contraindicated in accordance with the summary of product characteristic
Beschreibung

Contraindication

Datentyp

boolean

Alias
UMLS CUI [1]
C1301624
Patients who take part in interventional clinical trials parallel or during the last 4 weeks
Beschreibung

Study Participation Status

Datentyp

boolean

Alias
UMLS CUI [1]
C2348568
Patient shows conditions or diseases that might disturb the monitoring according to the physician
Beschreibung

Comorbidity

Datentyp

boolean

Alias
UMLS CUI [1]
C0009488
Patients with substance misuse in their case history (drugs, alcohol) or with other factors (e.g. serious psychiatric conditions) that limit their ability to participate in the study
Beschreibung

Substance Use Disorder

Datentyp

boolean

Alias
UMLS CUI [1]
C2702800
Insufficient German language knowledge to understand the patient education and to complete the questionnaires in a correct manner
Beschreibung

Language Ability

Datentyp

boolean

Alias
UMLS CUI [1]
C1145677
Patients involved in the planning and construction of the study (Teva staff and employees of the centres)
Beschreibung

Study planning

Datentyp

boolean

Alias
UMLS CUI [1]
C0681871
Patient is incapable of giving consent
Beschreibung

Incapable of giving informed consent

Datentyp

boolean

Alias
UMLS CUI [1,1]
C0021430
UMLS CUI [1,2]
C1550518
Zum Seitenanfang zurückkehren

Ähnliche Modelle

Eligibility Asthma and COPD Treatment NCT02384577 DRKS00006542

1 Formulare
Name
Typ
Description | Question | Decode (Coded Value)
Datentyp
Alias
Item Group
Inclusion Criteria
C1512693 (UMLS CUI-1)
Age
Item
Ages Eligible for Study: 18 Years and older (Adult, Senior)
boolean
C0001779 (UMLS CUI [1])
Asthma or COPD
Item
Male and female adult patients with clinical diagnosis of bronchial asthma or chronic obstructive pulmonary disease
boolean
C0004096 (UMLS CUI [1])
C0024117 (UMLS CUI [2])
Inhaled corticosteroids and long-acting beta-2-agonists
Item
Patients on regular medication with inhaled corticosteroids and long-acting beta-2-agonists in fixed-dose combination
boolean
C2065041 (UMLS CUI [1])
C0001644 (UMLS CUI [2,1])
C0205166 (UMLS CUI [2,2])
Change of medication
Item
Patients who recently changed medication to DuoResp® Spiromax or are about to do so
boolean
C0580105 (UMLS CUI [1])
Informed Consent
Item
Capacitated person with present declaration of consent
boolean
C0021430 (UMLS CUI [1])
Item Group
Exclusion Criteria
C0680251 (UMLS CUI-1)
Contraindication
Item
Diseases contraindicated in accordance with the summary of product characteristic
boolean
C1301624 (UMLS CUI [1])
Study Participation Status
Item
Patients who take part in interventional clinical trials parallel or during the last 4 weeks
boolean
C2348568 (UMLS CUI [1])
Comorbidity
Item
Patient shows conditions or diseases that might disturb the monitoring according to the physician
boolean
C0009488 (UMLS CUI [1])
Substance Use Disorder
Item
Patients with substance misuse in their case history (drugs, alcohol) or with other factors (e.g. serious psychiatric conditions) that limit their ability to participate in the study
boolean
C2702800 (UMLS CUI [1])
Language Ability
Item
Insufficient German language knowledge to understand the patient education and to complete the questionnaires in a correct manner
boolean
C1145677 (UMLS CUI [1])
Study planning
Item
Patients involved in the planning and construction of the study (Teva staff and employees of the centres)
boolean
C0681871 (UMLS CUI [1])
Incapable of giving informed consent
Item
Patient is incapable of giving consent
boolean
C0021430 (UMLS CUI [1,1])
C1550518 (UMLS CUI [1,2])
Zum Seitenanfang zurückkehren 

Kontakt

Benutzen Sie dieses Formular für Rückmeldungen, Fragen und Verbesserungsvorschläge.

Mit * gekennzeichnete Felder sind notwendig.

Hilfe

Benötigen Sie Hilfe bei der Suche? Um mehr Details zu erfahren und die Suche effektiver nutzen zu können schauen Sie sich doch das entsprechende Video auf unserer Tutorial Seite an.

Zum Video